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Gene 1 of the human coronavirus HCV 229E encompasses approximately 20.7 kb and contains two overlapping open
reading frames, ORF 1a and ORF 1b. The downstream ORF 1b is expressed by a mechanism involving (01) ribosomal
frameshifting. Translation of mRNA 1, which is thought to be equivalent to the viral genomic RNA, results in the synthesis
of two large polyproteins, pp1a and pp1ab. These polyproteins contain motifs characteristic of papain-like and 3C-like
proteinases, RNA-dependent RNA polymerases, helicases, and metal-binding proteins. In this study, we have produced
pp1ab-specific monoclonal antibodies and have used them to detect an intracellular, 105-kDa viral polypeptide that contains
the putative RNA polymerase domain. Furthermore, using trans cleavage assays with bacterially expressed HCV 229E 3C-
like proteinase, we have demonstrated that the 105-kDa polypeptide is released from pp1ab by cleavage at the dipeptide
bonds Gln-4068/Ser-4069 and Gln-4995/Ala-4996. These data contribute to the characterization of coronavirus 3C-like
proteinase-mediated processing of pp1ab and provide the first identification of an HCV 229E ORF 1ab-encoded polypeptide
in virus-infected cells. q 1996 Academic Press, Inc.
INTRODUCTION thesis of the coronavirus RNA polymerase involves the
activity of proteinases that cleave pp1a and pp1ab into
Human coronaviruses (HCV) are a major cause of up-
smaller, functional polypeptides (Leibowitz et al., 1982;
per respiratory tract illness in man, and their involvement
Schaad et al., 1990; Baric et al., 1990; Fu and Baric, 1994).
in lower respiratory tract illness and gastroenteritis is
Sequence motifs characteristic of both papain-like and
probable (Zhang et al., 1994; Myint, 1995; Johnston and
picornavirus 3C proteinases have been identified in the
Holgate, 1996). To date, two antigenic groups of HCV
predicted sequences of pp1a and pp1ab and motifs that
have been identified and they are represented by the
are associated with replicative functions (such as RNA
prototype strains HCV 229E and HCV OC43. Since HCV
polymerase, helicase, and metal-binding domains) have
229E is easier to isolate and propagate in tissue culture,
been conserved in the pp1ab sequence (Eleouet et al.,
it has been more extensively studied.
1995; Gorbalenya et al., 1989; Herold et al., 1993; Lee et
The HCV 229E genome is a positive-strand RNA of
al., 1991). An obvious goal of research in this area is,
approximately 27,000 nucleotides. Gene 1, which is lo-
therefore, to define the role of coronavirus proteinases
cated at the 5* end of the genome, is composed of two
in the processing of the polymerase gene products.
large, overlapping ORFs, ORF 1a and ORF 1b (Herold et
Recently, considerable progress has been made in
al., 1993). The upstream ORF 1a encodes a polyprotein
characterizing the activities of coronaviral 3C-like pro-
pp1a, with a calculated molecular mass of 454 kDa. The
teinases. Lu et al. (1995) have shown that the MHV 3C-
downstream ORF 1b is expressed as a fusion protein
like proteinase synthesized in vitro is able to cleave MHV
with pp1a by a mechanism involving (01) ribosomal
pp1a and pp1ab at the dipeptide bond Gln-3334/Ser-
frameshifting (Herold et al., 1993; Herold and Siddell,
33352 and they have identified Cys-145 and His-41 as
1993). The ORF 1ab gene product has a calculated mo-
proteinase residues that are essential for this activity.
lecular mass of 754 kDa and is referred to as polyprotein
Using a vaccinia virus-T7 expression system, Liu et al.
1ab or pp1ab.
(1994) have shown that the IBV 3C-like proteinase is
The analysis of murine hepatitis virus temperature-
involved in the processing of IBV pp1ab to produce a
sensitive mutants provides strong evidence that the syn-
100-kDa polypeptide that includes the RNA polymerase
motif. Mutational analyses suggest that the 100-kDa poly-
1 To whom correspondence and reprint requests should be ad-
dressed at Institute of Virology, University of Wu¨rzburg, Versbacher
Strasse 7, 97078 Wu¨rzburg, Germany. Fax: /49-931-201-3934. E-mail: 2 The numbering of RNA polymerase amino acids used here follows
the conventions adopted by individual authors.siddell@rzbox.uni-wuerzburg.de.
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peptide is released by cleavage at the dipeptide bonds Bsp106I DNA restriction fragment from plasmid pBS-
T16D8 was ligated to Bsp106I-linearized DNA of plasmidGln-3928 (1a)/Ser-3929 (1a) and Gln-891 (1b)/Ser-892
(1b). The IBV 3C-like proteinase residues Cys-2922 and pT7/7 (Tabor and Richardson, 1985). This construct en-
codes a fusion protein of 537 amino acids; 19 artifactualHis-2820 are essential for this activity (Liu and Brown,
1995). In our own studies, both the autoproteolytic activity amino acids at the amino terminus, 506 amino acids
corresponding to amino acids 4084 to 4589 of the HCVand trans cleavage activity of a bacterially expressed
HCV 229E 3C-like proteinase have been demonstrated. 229E polyprotein 1ab, and 12 additional vector-derived
amino acids at the carboxyl terminus.Sequence analysis has shown that the amino-terminal
cleavage of the HCV 229E proteinase domain occurs at
Expression and purification of bacterial fusionthe HCV pp1a and pp1ab dipeptide bond Gln-2965/Ala-
proteins2966. Finally, we have also been able to detect a 34-kDa,
3C-like proteinase polypeptide in HCV 229E-infected
Plasmids pUR290 and pUR-K3 were used to transform
cells (Ziebuhr et al., 1995).
E. coli BMH 71-18 cells, and plasmid pT7-F10 was used
In the current study, we report the detection of a 105-
to transform E. coli BL21 (DE3) cells. Induction of expres-
kDa polypeptide in HCV 229E-infected cells using mono-
sion, preparation of cell lysates, separation on prepara-
clonal antibodies specific for epitopes near the polymer-
tive SDS–polyacrylamide gels, electroelution of fusion
ase domain of pp1ab. To further characterize the termini
proteins, and dialysis were essentially performed as de-
of this polypeptide, we have used bacterially synthesized,
scribed (Ziebuhr et al., 1995).
HCV 229E 3C-like proteinase to cleave both in vitro syn-
thesized and bacterially synthesized substrates and we Production of monoclonal antibodies
have done N-terminal sequencing of the reaction prod-
Three-month-old female BALB/c mice were inoculateducts. These studies lead us to conclude that the RNA-
six times intraperitoneally with the partially purified K3dependent RNA polymerase domain of the human coro-
fusion protein. Fusion, screening, and cloning of hybrid-navirus 229E is expressed within a 105-kDa polypeptide
oma lines were performed by using standard techniquesencompassing amino acids 4069–4995 of the polypro-
(Harlow and Lane, 1988). Hybridomas were screenedtein 1ab.
for HCV 229E polymerase protein-specific antibodies by
enzyme-linked immunosorbent assay, using as captureMATERIALS AND METHODS
antigens K3 fusion protein, F10 fusion protein, or a crude
Cells and viruses lysate of proteins from bacteria overexpressing b-galac-
tosidase. Hybridomas secreting polymerase protein-spe-MRC-5 cells (ECACC 84101801) and HeLa cells (ATCC
cific antibodies were cloned three times by limiting dilu-CCL2) overexpressing human aminopeptidase N (HeLa-
tion. For the production of murine monoclonal antibodyCD13; Siddell, unpublished) were grown in monolayers
at concentrations of approximately 1 mg/ml, the TECNO-in minimal essential medium with Earle’s salts containing
MOUSE hollow fiber bioreactor system (INTEGRA BIO-10% heat-inactivated fetal bovine serum, 25 mM HEPES,
SCIENCES, Fernwald, Germany) was used. MonoclonalGLUTAMAX I, antibiotics, and nonessential amino acids
antibody isotypes were determined using the Sigma Im-(MEM10). The HCV 229E isolate used in these studies
munotype kit (092H-4800; Sigma, St. Louis, MO).has been described previously (Raabe et al., 1990). The
virus was propagated in monolayers of MRC-5 cells and
Epitope mapping
concentrated virus stocks were prepared by NaCl–poly-
ethylene glycol precipitation as described (Wege et al., An antibody–peptide binding assay was done using a
1979). library of peptides synthesized on a cellulose membrane
support (JERINI BIO-TOOLS, Berlin, Germany). The mem-
Construction of bacterial expression plasmids branes were incubated with concentrated tissue culture
supernatant, washed, and immunostained with an alka-
To generate the plasmid pUR-K3, DNA of the vector
line phosphatase-conjugated, secondary antibody using
pUR290 (Ru¨ther and Mu¨ller-Hill, 1983) was digested with
standard techniques (Harlow and Lane, 1988).
Bsp106I, and the 3256-base-pair (bp) fragment was iso-
lated and ligated to a 1518-bp AciI–Bsp106I fragment of Virus infection, cell lysis, and Western blotting
DNA from the plasmid pBS-T16D8 (Herold et al., 1993).
The plasmid pUR-K3 encodes a fusion protein containing HeLa–CD13 cells were infected with HCV 229E at an
m.o.i. of 10 PFU per cell. At different times after infection,the amino-terminal 280 amino acids of Escherichia coli
b-galactosidase, 506 amino acids corresponding to the cells were washed with ice-cold PBS and resus-
pended in PBS. After centrifugation (800 g, 47, 10 min),amino acids 4084 to 4589 of the HCV 229E pp1ab, and
6 artifactual amino acids at the carboxyl terminus. the cells were resuspended in lysis buffer (20 mM Tris–
Cl, pH 7.5, 150 mM NaCl, 0.5% sodium deoxycholate,To generate the plasmid pT7-F10, the 1518-bp, AciI –
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1% Nonidet-P40, 0.1% SDS) and left for 15 min on ice. fragment was generated from pBS-T16D8DFS DNA by a
PCR reaction with the oligonucleotides 5* ACGGGATCC-Subsequently, the lysates were centrifuged (14,000 g, 47,
10 min) and the supernatants were mixed with 1 volume AATGGCTGGCAAACAGACTGAGTTT 3* and 5* ACACAC-
GGTGTATGTCCTCATT 3*. The DNA fragment wasof 21 SDS–PAGE sample buffer. Proteins were sepa-
rated on SDS–12.5% polyacrylamide gels and Western treated with T4 DNA polymerase, phosphorylated with
polynucleotide kinase, digested with BamHI, and ligatedblotting and immunostaining were performed using stan-
dard procedures (Gallagher et al., 1991). with BamHI/EcoRV-digested pBS-T. Synthetic mRNA de-
rived from the resultant plasmid, pBSS3, encodes a poly-
peptide encompassing amino acids 3934 to 4237 ofPreparation of proteinase substrates
pp1ab.
Bacterially synthesized substrates. To construct pMal-In vitro synthesized substrates. Two different strategies
were used to express, in vitro, HCV 229E pp1ab polypep- Npol, pBSS3 DNA was digested with BamHI, treated with
T4 DNA polymerase, and digested with HindIII. The 923-tides that would serve as substrates for trans cleavage
assays. First, polyadenylated RNA from HCV 229E-in- bp DNA fragment was isolated and ligated with XmnI/
HindIII-digested pMal-c2 DNA (800-64S; New Englandfected cells was isolated and reverse transcription using
the oligonucleotide, 5* TCACATTGCATAAGCATCACT- Biolabs; Schwalbach, Germany). pMal-Cpol encodes
amino acids 3934 to 4237 of the HCV 229E polyproteinAACAT 3*, was done as described (Herold et al., 1996).
Subsequently, a cDNA fragment containing nucleotides 1ab fused to the E. coli maltose-binding protein (MBP).
To generate plasmid pMal-Cpol, a cDNA fragment con-14,599–16,069 of the HCV 229E genome was amplified
by a PCR reaction using the RT primer and the oligonu- taining nucleotides 14,599 to 16,069 of the HCV 229E
genomic sequence was amplified by PCR using oligonu-cleotide 5* TAATACGACTCACTATAGGGCCTTGGTTTT-
GAGCGTTAACTCGTCA 3*. This second primer contains cleotides 5* CGGGATCCCGTTTTGAGCGTTAACTCG 3*
and 5* TTGCATAAGCATCACTAACATACACT 3* and pBS-the bacteriophage T7 promoter, which allows for the in
vitro transcription of the purified PCR product using T7 T13A5 DNA template (Herold et al., 1993). The PCR prod-
uct was treated with T4 DNA polymerase and polynucleo-RNA polymerase without subcloning. The synthetic
mRNA produced encodes a polypeptide that encom- tide kinase, digested with HincII, and ligated with XmnI-
digested pMal-c2 DNA. pMal-Cpol encodes amino acidspasses amino acids 4818 to 5259 of pp1ab.
A second pp1ab polypeptide, encompassing the 4774 to 5259 of the HCV 229E polyprotein 1ab fused to
the E. coli maltose-binding protein.amino acids 3934 to 4237, was synthesized from mRNA
derived from the plasmid pBSS3. To introduce mutations Trans cleavage assay using in vitro synthesized sub-
strates. Capped mRNA was synthesized by in vitro tran-into the slippery sequence and the frameshifting site lo-
cated in the RNA polymerase locus of HCV 229E, recom- scription of PCR-amplified DNA or HindIII-linearized
pBSS3 DNA using standard protocols. Translation reac-bination PCR technology was used as previously de-
scribed (Ziebuhr et al., 1995). To generate the required tions were done in a rabbit reticulocyte lysate (Promega/
Serva, Heidelberg, Germany) in the presence of [35S]-PCR fragments, four oligonucleotides, 5* TCTTCAGCA-
TCTTTTACTTTC 3*, 5* GAAAGTAAAAGATGCTGAAGA 3*, methionine (Herold and Siddell, 1993). Trans cleavage
assays were done as previously described (Ziebuhr et5* GTTATCTGAATAGGGTCCGGGGCTCTAGTGCCGCT
3*, 5* CGGACCCTATTCAGATAACTGTTATCAAAACTTTG al., 1995) except that 10 mg of HCV 229E 3C-like protein-
ase (1 mg/ml in 20 mM Bis–Tris–Cl, pH 7.0), purified by3*, and pBS-T16D8 template DNA were used. The muta-
genesis procedure exchanged nucleotide 12515 (T for anion exchange and hydrophobic interaction chromatog-
raphy, was used.C), nucleotide 12517 (A for G), and nucleotides 12520 to
12522 (CGA for TAG) in relation to the HCV 229E genomic Trans cleavage assay using bacterially synthesized sub-
strates and amino-terminal protein sequence analysis.sequence. These mutations and the introduction of an
additional nucleotide (G) at position 12523 link the coding The plasmids pMal-Npol and pMal-Cpol were used to
transform competent E. coli TB1 cells. The recombinantsequences of ORFs 1a and 1b to create an ORF that
encodes a polypeptide corresponding to a region of the proteins were expressed and affinity-purified as de-
scribed previously (Ziebuhr et al., 1995). The fusion pro-predicted polyprotein 1ab. The mutations introduced to
the resultant plasmid, pBS-T16D8DFS, were verified by teins were incubated for 24 hr at 337 with 10 mg of 3C-like
proteinase. Following incubation, the cleavage productsDNA sequence analysis.
Next, the T7 expression plasmid pBS-T was generated were separated on SDS–15% polyacrylamide gels and
transferred electrophoretically to a polyvinylidene difluor-by digestion of pBluescript II (KS/) DNA (Stratagene
GmbH, Heidelberg, Germany) with SacI and BamHI and ide (PVDF) membrane (Bio-Rad Laboratories, Mu¨nchen,
Germany). The membrane was stained in 0.025% (w/v)ligation to the annealed oligonucleotides 5* GATCCA-
TGGTGGACTGCGAGCT 3* and 5* CGCAGTCCACCATG Coomassie brilliant blue R-250 in 40% (v/v) methanol and
destained in 50% (v/v) methanol. The appropriate areas3*. This plasmid provides a translation start codon in
an optimal context (Kozak, 1984). Finally, a 908-bp DNA of the membrane were isolated and the N-terminal se-
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FIG. 1. Schematic presentation of HCV 229E gene 1 expression. Putative functional domains within polyproteins pp1a and pp1ab (Gorbalenya
et al., 1989; Herold et al., 1993) are shown. The amino-terminal cleavage site of the 3C-like proteinase domain (Ziebuhr et al., 1995) is designated
by solid triangles, and the predicted 3C-like proteinase-mediated cleavages flanking the putative RNA polymerase domain (Gorbalenya et al., 1989;
Lee et al., 1991) are represented by open triangles. The amino acid numbering of pp1a and pp1ab including the ORF 1a/1b junction, as predicted
to occur (Brierley et al., 1992; Herold and Siddell, 1993), is given in the single-letter code. PCP, papain-like cysteine proteinase; 3CL, 3C-like
proteinase; GFL, growth factor/receptor-like domain; POL, RNA polymerase motif; MBD, metal binding domain; HEL, helicase domain.
quences of the bound proteins were determined by stan- a b-galactosidase-containing bacterial lysate (data not
shown). The isotypes of the MAbs were determined anddard procedures with a protein sequencer (Model 476A;
Applied Biosystems, Weiterstadt, Germany). are shown in Table 1. To define the epitopes recognized
RESULTS
TABLE 1
Production of polyprotein 1ab-specific monoclonal Isotype and Specificity of the Polyprotein 1ab-Specific MAbs
antibodies
Position in pp1ab
MAb Isotype Peptides recognizeda (amino acids)In order to produce monoclonal antibodies (MAbs)
specific for the HCV 229E polyprotein 1ab, we con-
6.13D7 IgG 2b KNVDKDDAFYIVK 4123–4135structed the bacterial expression plasmids pUR-K3 and
DKDDAFYIVKRCI 4126–4138
pT7-F10. The plasmid pUR-K3 contains a 1518-nucleotide DAFYIVKRCIKSV 4129–4141
region of the HCV 229E pol1b ORF, starting 21 nucleo-
7.12E3 IgG 1 KNVDKDDAFYIVK 4123–4135tides downstream of the ribosomal frameshifting site. In-
DKDDAFYIVKRCI 4126–4138
frame fusion of this coding region to the first 840 nucleo- DAFYIVKRCIKSV 4129–4141
tides of the E. coli lacZ gene allowed for the high-level
7.12G4 IgG 1 KNVDKDDAFYIVK 4123–4135expression of a 90-kDa fusion protein, K3 (Fig. 1). The
DKDDAFYIVKRCI 4126–4138
construct pT7-F10, encoding a minimal number of addi- DAFYIVKRCIKSV 4129–4141
tional amino acids at both termini of the same HCV se-
8.3E4 IgG 1 SRQDLTKYTMMDL 4177–4189quence, yielded lower levels of fusion protein expression
DLTKYTMMDLCFA 4180–4192
but was nevertheless useful for hybridoma screening.
8.6G5 IgG 1 TDYFEMKNWFDPI 4216–4228Using the partially purified K3 protein as antigen, five
FEMKNWFDPIENE 4219–4231murine hybridoma cell lines secreting HCV 229E polypro-
KNWFDPIENEDIH 4222–4234
tein 1ab-specific monoclonal antibodies were obtained.
All of the MAbs reacted specifically in ELISA and Western a Consensus recognition sequences common to all of the peptides
reacting with a given MAb are shown in boldface.blotting with the K3 and F10 fusion proteins but not with
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ent HeLa–CD13 cells at an m.o.i of 10 PFU per cell,
harvested the cells at different times after infection, pro-
duced cell lysates, and analyzed them by SDS–PAGE
and Western blotting using the panel of MAbs described
above. A protein with an apparent molecular mass of 105
kDa was specifically detected by MAb 8.6G5 in lysates
from infected, but not from mock-infected, cells (Fig. 2).
Using this approach, the earliest time point at which the
105-kDa polypeptide could be detected was 7 hr after
infection. The 105-kDa polypeptide was recognized by
all of the available pp1ab-specific MAbs but not by a
b-galactosidase-specific control MAb 6D2H4 (data not
shown; Ziebuhr et al., 1995). Since three of the antibodies
used in the immunoblot experiments differ in their speci-
ficity, the experiments show that the 105-kDa protein
must contain, at least, amino acids 4129 to 4228 of the
1ab polyprotein.
Determination of the termini of the 105-kDa
polypeptide
To define the termini of the 105-kDa protein we de-FIG. 2. Expression of the bacterial fusion protein K3 containing a
cided to utilize the trans activity of the HCV 229E 3C-4084–4589 of the HCV 229E pp1ab. Cell lysates from noninduced
(lanes 2 and 4) or IPTG-induced (lanes 3 and 5) E. coli BMH 71-18 like proteinase reported previously (Ziebuhr et al., 1995).
cells transformed with plasmids pUR290 (lanes 2 and 3) or pUR-K3 First, two in vitro synthesized polypeptides, representing
(lanes 4 and 5) were separated by SDS–PAGE in a 10% polyacrylamide amino acids 3934 to 4237 and 4818 to 5259 of the HCV
gel and stained with Coomassie brilliant blue R-250. Protein molecular
229E pp1ab, were used as substrates in a cleavagemarkers (17-0446-01; Pharmacia Biotech, Freiburg, Germany) are
assay. Each polypeptide contained one predicted cleav-shown in lane 1. The HCV 229E-encoded regions of the fusion protein
K3 and the localization of the MAb epitopes within pp1ab is indicated. age site, the dipeptide bonds Gln-4068/Ser-4069 and
Gln-4995/Ala-4996, respectively (Gorbalenya et al., 1989;
Herold et al., 1993). After incubation with bacterially ex-by these MAbs, a library of peptides was synthesized
pressed, purified 3C-like proteinase, each of the primaryconsisting of 13-mer peptides, each overlapping its
translation products was cleaved specifically into twoneighbor by 10 amino acids. The library encompasses
polypeptides (Fig. 3). The translation product containingthe 506-amino-acid, polyprotein 1ab region contained in
the predicted N-terminal cleavage site of the polymerasethe K3 fusion protein.
domain, with an apparent molecular mass of 36 kDa, wasThe MAbs 6.13D7 and 7.12E3 both reacted with three
consecutive peptides covering the amino acid sequence
KNVDKDDAFYIVKRCIKSV. This sequence is located at
amino acid positions 4123 to 4141 in pp1ab. MAb 7.12G4
reacted with two of the same peptides. MAb 8.3E4
showed binding activity with two consecutive peptides
encompassing the sequence SRQDLTKYTMMDLCFA,
i.e., amino acid positions 4177 to 4192 in pp1ab. The
binding site for MAb 8.6G5 was located within the se-
quence TDYFEMKNWFDPIENEDIH, which is repre-
sented by three neighboring peptides in the library and
corresponds to pp1ab amino acids 4216 to 4234. The
amino acid sequences of the peptides recognized by
individual antibodies, as well as their position in the HCV
229E polyprotein 1ab, are summarized in Table 1 and
their locations are indicated in Fig. 2. FIG. 3. Detection of a 105-kDa polypeptide in HCV 229E-infected
cells. Cell lysates from mock-infected (lane 6) and HCV 229E-infected
Identification of a 105-kDa, gene 1-encoded protein in (lanes 1 to 5) HeLa–CD13 cells (5 1 105) were analyzed by SDS–
PAGE and Western blot using the pp1ab-specific MAb 8.6G5. LysatesHCV 229E-infected cells
were obtained at 3 (lane 1), 5 (lane 2), 7 (lane 3), 9 (lane 4), and 11 hr
To study the expression of the HCV 229E gene 1 in p.i. (lanes 5 and 6). Molecular weight markers (CFA 626; Amersham,
Braunschweig, Germany) are shown.virus-infected cells, we mock-infected or infected conflu-
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FIG. 4. Trans cleavage assay with in vitro synthesized substrates containing the predicted amino- and carboxyl-terminal regions of the 105-kDa,
ORF 1ab-encoded polypeptide. Protein molecular weight marker (CFA 645; Amersham, Braunschweig, Germany; lane 1); in vitro translation product
of PCR product-derived mRNA (aa 3934–4237 of pp1ab) without incubation (lane 2), after incubation with buffer (lane 3) or buffer containing 10 mg
bacterially expressed 3C-like proteinase (lane 4); translation product of pBSS3-derived mRNA (aa 4818–5259 of pp1ab) without incubation (lane 5),
after incubation with buffer (lane 6) or buffer containing 10 mg bacterially expressed 3C-like proteinase (lane 7). The primary translation products
and cleavage products are indicated, and their apparent molecular masses are given. Autoradiography was done for 48 hr.
cleaved into two polypeptides with apparent molecular the pMal-Npol fusion protein, containing the predicted
N-terminal cleavage site of the polymerase domain withmasses of 20 and 16 kDa. This result is consistent with
cleavage at the predicted dipeptide bond Gln-4068/Ser- an apparent molecular mass of 76 kDa, was cleaved into
two polypeptides with apparent molecular masses of 554069. The translation product containing the predicted
C-terminal cleavage site of the polymerase domain, with and 21 kDa. The pMal-Cpol fusion protein, containing
the predicted C-terminal cleavage site of the polymerasean apparent molecular mass of 50 kDa, was cleaved into
two polypeptides with apparent molecular masses of 27 domain with an apparent molecular mass of 94 kDa, was
cleaved into two polypeptides with apparent molecularand 23 kDa. This result is consistent with cleavage at the
predicted dipeptide bond Gln-4995/Ala-4996. In control masses of 66 and 28 kDa. These results are consistent
with cleavage at the predicted sites and the data shownreactions with identical buffer conditions, no specific
cleavage products were produced. Moreover, a transla- in Fig. 3. Again, no specific cleavage products were pro-
duced in control reactions.tion product encompassing nearly the complete putative
RNA polymerase domain (amino acids 4085 to 4895 of Finally, the 21- and 28-kDa cleavage products of the
pMal-Npol and pMal-Cpol fusion proteins were sepa-pp1ab) was shown to be resistent to cleavage with re-
combinant 3C-like proteinase (data not shown). rated on SDS–polyacrylamide gels, transferred to PVDF
membranes, isolated, and subjected to N-terminal se-Second, based upon the data obtained with in vitro
synthesized substrates, we expressed, in bacteria, HCV quence analysis. The N-terminal protein sequence of the
21-kDa (pMal-Npol) cleavage product was determined229E pp1ab polypeptides as part of E. coli MBP fusion
proteins. Incubation of the purified fusion proteins with to be Ser-Phe-Asp-Asn-Ser-Tyr-Leu, representing amino
acids 4069 to 4075 of HCV 229E pp1ab, and the N-termi-3C-like proteinase was then used to obtain specific pro-
teolytic reaction products. Thus, as is shown in Fig. 4, nal protein sequence of the 28-kDa (pMal-Cpol) cleavage
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product was determined to be Ala-Ala-Gly-Leu-Cys-Val-
Val, representing amino acids 4996 to 5002 of the HCV
229E 1ab polyprotein (Herold et al., 1993). These data
show that two 3C-like proteinase-mediated cleavages,
at dipeptide bonds Gln-4068/Ser-4069 and Gln-4995/Ala-
4996, release the putative RNA polymerase domain from
the HCV 229E 1ab polyprotein in the form of a 926-amino-
acid polypeptide with a calculated molecular mass of
105.5 kDa.
DISCUSSION
In this study, we have identified, in virus-infected cells,
a 105-kDa viral polypeptide that is encoded in the HCV
229E ORFs 1a and 1b. The identity of the polypeptide
has been established by reactivity with monoclonal anti-
bodies of defined specificity. We have also shown that
the 105-kDa polypeptide is released from the gene 1-
encoded polyprotein precursor, pp1ab, by cleavage at
the dipeptide bonds Gln-4068/Ser-4069 and Gln-4995/
Ala-4996, a reaction that is mediated by the HCV 229E
3C-like proteinase.
The detection of coronavirus gene 1-encoded polypep-
tides in the virus-infected cell is proving to be a laborious
task. The results shown here, and our previous work
on the expression of the HCV 229E 3C-like proteinase
(Ziebuhr et al., 1995), indicate that, at least in the early
stages of infection, these proteins are present in the cell
in exceedingly low amounts. Indeed, the data suggest
that it is only possible to detect polymerase translation
products after the infection has progressed into the
phase of genomic and subgenomic mRNA amplification.
Also, as may have been predicted from in vitro studies on
the level of HCV 229E mRNA 1 ribosomal frameshifting
(Herold and Siddell, 1993), we have found it more difficult
to identify pp1ab-derived products compared to those
derived from pp1a. For example, our attempts to immuno-
precipitate the 105-kDa polypeptide using polyclonal an-
tiserum, an approach which has proven successful for
the detection of the HCV 229E 3C-like proteinase, have
failed to produce convincing results. Obviously, if it is
only possible to detect stable translation products as
they accumulate in the virus-infected cell, it is going to
be difficult to obtain detailed information on the expres-
sion and processing of the HCV 229E 1a and 1ab poly-
proteins. On the basis of the data obtained so far, a
quantitative comparison of the amounts of ORF 1a-en-
coded (Ziebuhr et al., 1995) and ORF 1b-encoded poly-
peptides is, in our opinion, not possible. For example,
the characteristics of the primary and secondary antibod-
ies and the immunological assays that have been used
in these studies are very different. Also, the genesis of
gene 1-encoded polypeptides involves proteolytic pro-
cessing, and we do not have any data on the kinetics of
this process. Finally, there is no information concerning
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FIG. 5. Trans cleavage of bacterially synthesized MBP fusion proteins containing the predicted amino- and carboxyl-terminal regions of the 105-
kDa, ORF 1ab-encoded polypeptide. Reaction products were separated on an SDS–15% polyacrylamide gel and stained with Coomassie brilliant
blue. Protein molecular weight markers (17-0446-01; Pharmacia Biotech, Freiburg, Germany; lane 1); MBP fusion protein encoded by pMal-Npol
after incubation with buffer (lane 2) or after incubation with 10 mg 3C-like proteinase (lane 3); MBP fusion protein encoded by pMal-Cpol after
incubation with buffer (lane 4) or after incubation with 10 mg 3C-like proteinase (lane 5). The fusion proteins and cleavage products are indicated
and their apparent molecular masses are given. Additionally, the amino-terminal sequences of the 21- and 28-kDa cleavage products are shown.
nor have any protein–protein interactions that might in- and are not recognized as cleavage sites in the trans
cleavage assays.terfere with antibody recognition been investigated.
The processing of the 105-kDa protein is mediated The 105-kDa polypeptide contains an RNA polymerase
motif that has been identified by computer-aided sequenceby the HCV 229E 3C-like proteinase. Information on the
substrate specificity of coronaviral 3C-like proteinases is comparisons with a variety of related cellular and viral en-
zymes (amino acids 4606 to 4908 of HCV 229E polyproteinlimited, but comparison of the four cleavage sites that
have been determined by sequence analysis to date (Ta- 1ab; Gorbalenya et al., 1989; Herold et al., 1993). This sug-
gests that this polypeptide will have a central role in theble 2; Lu et al., 1995; Ziebuhr et al., 1995) suggests that,
besides conservation at the P1 and P1* sites (Gln/Ala, replication and transcription of viral RNA. Experiments de-
signed to demonstrate an RNA polymerase activity associ-Ser), the P2 site appears to be represented by hydropho-
bic residues, mainly Leu. The presence of Ile at the P2 ated with, for example, bacterially expressed 105-kDa poly-
peptide are in progress. However, even if, for example, asite of the HCV 229E amino-terminal polymerase cleav-
age site indicates, however, that a certain variability is poly(A)-dependent oligo(U)-primed poly(U) polymerase ac-
tivity could be demonstrated for this polypeptide, this wouldallowed at this position. It is likely, therefore, that different
hydrophobic residues, present at the analogous position still represent only one of the many gene functions required
for virus replication. Clearly, an integrated approach involv-of other coronavirus 1a and 1ab polyproteins (Val, Phe,
Met), may be part of functional substrate target sites ing both biochemistry and genetics will be needed to eluci-
date the structure–function relationships of the coronavirusof the 3C-like proteinase. To what extent this variability
contributes to the cleavage efficiency at different sites RNA polymerase complex.
remains to be investigated. It should be noted that the
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